Grants and Contributions

To construct critical infrastructure to enhance airport safety

This project is to build a Good Manufacturing Practices (GMP) facility to manufacture lipids, conduct lipid nanoparticle (LNP) formulation and expand the company's existing vaccine manufacturing capacity in Calgary, AB.

The project is focusing on Phase 3 pivotal study of LAU-7b in moderate-to-severe hospitalized COVID-19 patients, and has a component allowing the transition to a new Phase 2 clinical development in mild-to-moderate non-hospitalized COVID-19 patients.

LAU-7b is a next-generation COVID-19 antiviral that addresses the gap between early infection and critical COVID-19 disease, and aims for broad applicability at-home or in hospital. Because its host-directed mechanism, LAU-7b has the potential to work on all mutations of COVID-19, and other coronaviruses. Results from the Phase 2 pilot study showed 100% reduction in the risk of progression to mechanical ventilation and death in hospitalized moderate-to-severe patient.

The course was developed by CPKN and is currently launched on the online training portal for law enforcement to access. Unforeseen COVID-19 pressures on first responders had a direct impact on course completion numbers and an extension is being requested for continued support to allow free online course access to December 31, 2023 in order to maximize its uptake across Canada.

The City’s Master Transportation Plan was adopted in 2015 and includes a cycling network plan; however, there have been significant advances in accessibility and safety, as well as the COVID-19 pandemic, which have created generational changes in how people move around urban areas.

Examples include but are not limited to; (i) antigens derived from SARS-CoV-2 whose presence in asymptomatic individuals is indicative of exposure or infection, (ii) cardiac troponin which when elevated is indicative of cardiac risk, (iii) various cytokine markers related to the "cytokine storm" seen in COVID-19 patients.

The COVID-19 pandemic has generated an increased consumption of disposable personal protective equipment (PPE) by healthcare workers and by the general public. As of June 29, 2020, based on federal government projections for PPE demand over the next year, it is estimated that approximately 63,000 tonnes of COVID-19 related PPE will end up as waste, being ultimately landfilled.

This project will develop novel vaccines for brucellosis and tuberculosis, new diagnostic tests and advanced genomic tests to differentiate subspecies of bison in Canada.

This project aims to procure, deliver and install three CT scanners to three public hospitals in Egypt serving the lower to lower-middle income populations, which include the 1) Kafr El Zayat General Hospital (Lower Egypt); 2) Monofia General Hospital (Upper Egypt); and 3) Imbaba General Hospital (Greater Cairo). The project will also see the provision of will also of training to hospital staff on operating and maintaining the scanners. This project intends to provide health services to the over 20 million inhabitants, including poor and vulnerable women and men, living in the densely-populated and urban governorates of Gharbia, Monofiya & Giza.

The purpose of this Agreement is to support eligible organizations providing existing crisis hotlines responding to gender-based violence (GBV) that are experiencing a rise in call volumes due to the COVID-19 pandemic by agreeing on the term of payments of federal funding intended for these eligible organizations.